CDK7 inhibitor THZ1 inhibits MCL1 synthesis and drives cholangiocarcinoma apoptosis in combination with BCL2/BCL-XL inhibitor ABT-263

Cholangiocarcinoma (CCA) is a fatal disease without effective targeted therapy. We screened a small-molecule library of 116 inhibitors targeting different targets of the cell cycle and discovered several kinases, including Cyclin-dependent kinase 7 (CDK7) as vulnerabilities in CCA. Analysis of multi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Tianlu, Ding, Xiwei, Xu, Guifang, Chen, Gang, Cao, Yu, Peng, Chunyan, Shen, Shanshan, Lv, Ying, Wang, Lei, Zou, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688996/
https://www.ncbi.nlm.nih.gov/pubmed/31399555
http://dx.doi.org/10.1038/s41419-019-1831-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688996/
https://www.ncbi.nlm.nih.gov/pubmed/31399555
http://dx.doi.org/10.1038/s41419-019-1831-7

Ejemplares similares